Please use this identifier to cite or link to this item:
Title: Angiotensin converting enzyme inhibitors in perspective: an update.
Austin Authors: Burrell, Louise M ;Johnston, Colin I
Affiliation: General Medicine
Issue Date: 1-Jul-1993
Publication information: Australian Family Physician; 22(7): 1243-7, 1251, 1255
Abstract: Orally active inhibitors of angiotensin converting enzyme (ACE) have made a major impact on the clinical therapy of hypertension, congestive cardiac failure and ventricular remodelling after myocardial infarction. The ACE inhibitors combine the advantages of efficacy and low incidence of side effects, with the promise of cardio-, vasculo- and reno- protection.
Journal: Australian Family Physician
Type: Journal Article
Subjects: Age Factors
Angiotensin-Converting Enzyme Inhibitors.pharmacology.therapeutic use
Diabetic Nephropathies.drug therapy
Drug Therapy, Combination
Heart Diseases.drug therapy
Hemodynamics.drug effects
Hypertension.drug therapy
Hypertension, Renal.drug therapy
Hypertension, Renovascular.drug therapy
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Apr 12, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.